Chronic Hepatitis B In Children: Case Series From A Tertiary Paediatric Hospital
Klinische Pädiatrie · 01.07.2025 · 237 (04) · 202-208
DOI: 10.1055/a-2135-2000 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Klinische Pädiatrie, erschienen am 01.07.2025. Verfasst von Fazilcan Zirek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Pulmonology, Ankara Universitesi Tip Fakultesi, Ankara, Turkey. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Antiviral Agents, Tertiary Care Centers, Hospitals, Pediatric. Die Arbeit nennt 30 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Chronic hepatitis B (CHB) remains an important global public health problem. Seroconversion is highly correlated with favourable long-term outcome. There is no consensus on the treatment method, onset time and duration for paediatric CHB patients. In this study, we aimed to evaluate the course of children with CHB, to determine the characteristics of the patients who developed spontaneous seroconversion and treatment indications, and to compare the effectiveness of different treatment modalities. Patients and Methods Patients aged 1–18 years with a diagnosis of CHB were included in this study and evaluated for the development of spontaneous hepatitis B envelope antigen (HBeAg)/surface antigen (HBsAg) seroconversion and treatment modalities. The treated patients were divided into two groups according to their treatment regimen.
Results
Of the 114 patients, the median age at diagnosis was 8.4 years and median follow-up period was 5.2 years. Spontaneous HBeAg and HBsAg seroconversion developed in 18 (20.6%) of 87 HBeAg positive patients and two (1.8%) patients, respectively. Thirty-one patients were treated. The follow-up period was higher in the group with HBeAg seroconversion (p:0.005). There was no statistical difference between the patients in terms of seroconversion development and treatment status. The serum alanine aminotransferase (ALT) values at the time of diagnosis were statistically higher in treated patients.
Conclusion
HBV infection and CHB continue to be an important problem for children in our country. Consensus on the appropriate ALT ULN is needed for the treatment of hepatitis in children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pediatric Pulmonology, Ankara Universitesi Tip Fakultesi, Ankara, Turkey.
- Pediatric Gastroenterology, SBU Ankara Dr Sami Ulus Maternity Child Health and Diseases Training and Research Hospital, Ankara, Turkey.
- Pediatrics, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Ankara, Turkey.
ORCID-Profile: Fazilcan Zirek
Zitieren
APA
Zirek, F., Hosnut, F. O., Sahin, G., & Senel, S. (2025). Chronic Hepatitis B In Children: Case Series From A Tertiary Paediatric Hospital. Klinische Pädiatrie, 237(04), 202-208. https://doi.org/10.1055/a-2135-2000
Vancouver
Zirek F, Hosnut FO, Sahin G, Senel S. Chronic Hepatitis B In Children: Case Series From A Tertiary Paediatric Hospital. Klinische Pädiatrie. 2025;237(04):202-208. doi:10.1055/a-2135-2000
BibTeX
@article{Zirek2025,
author = {Zirek, Fazilcan and Hosnut, Ferda Ozbay and Sahin, Gulseren and Senel, Saliha},
title = {Chronic Hepatitis B In Children: Case Series From A Tertiary Paediatric Hospital},
journal = {Klinische Pädiatrie},
year = {2025},
volume = {237},
number = {04},
pages = {202--208},
doi = {10.1055/a-2135-2000}
}
EUVIMED